Novartis Investigative Site

Jeollanam 519763

0 studies enrolling now · 3 studies all time

What they study most

Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Immune Thrombocytopenia

Studies at this site

• Asciminib Roll-over Study — Recruiting now
• A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids — Running, not enrolling
• Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs — Completed